<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="review-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<!--The publisher of this article does not allow downloading of the full text in XML form.-->
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">J Assist Reprod Genet</journal-id>
<journal-id journal-id-type="iso-abbrev">J. Assist. Reprod. Genet</journal-id>
<journal-title-group>
<journal-title>Journal of Assisted Reproduction and Genetics</journal-title>
</journal-title-group>
<issn pub-type="ppub">1058-0468</issn>
<issn pub-type="epub">1573-7330</issn>
<publisher>
<publisher-name>Springer US</publisher-name>
<publisher-loc>New York</publisher-loc>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">27432256</article-id>
<article-id pub-id-type="pmc">5010819</article-id>
<article-id pub-id-type="publisher-id">765</article-id>
<article-id pub-id-type="doi">10.1007/s10815-016-0765-6</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Review</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>The impact of <italic>FMR1</italic> gene mutations on human reproduction and development: a systematic review</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Noto</surname>
<given-names>Vincenzo</given-names>
</name>
<xref ref-type="aff" rid="Aff1">1</xref>
<xref ref-type="aff" rid="Aff2">2</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Harrity</surname>
<given-names>Conor</given-names>
</name>
<xref ref-type="aff" rid="Aff1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Walsh</surname>
<given-names>David</given-names>
</name>
<xref ref-type="aff" rid="Aff1">1</xref>
</contrib>
<contrib contrib-type="author" corresp="yes">
<contrib-id contrib-id-type="orcid">http://orcid.org/0000-0003-3537-7281</contrib-id>
<name>
<surname>Marron</surname>
<given-names>Kevin</given-names>
</name>
<address>
<email>kevin.marron@sims.ie</email>
</address>
<xref ref-type="aff" rid="Aff1">1</xref>
</contrib>
<aff id="Aff1"><label>1</label>Sims Clinic, Clonskeagh, Dublin 14, Ireland </aff>
<aff id="Aff2"><label>2</label>Sims Clinic, Mahon Point, Cork, Ireland </aff>
</contrib-group>
<pub-date pub-type="epub">
<day>18</day>
<month>7</month>
<year>2016</year>
</pub-date>
<pub-date pub-type="ppub">
<month>9</month>
<year>2016</year>
</pub-date>
<volume>33</volume>
<issue>9</issue>
<fpage>1135</fpage>
<lpage>1147</lpage>
<history>
<date date-type="received">
<day>11</day>
<month>2</month>
<year>2016</year>
</date>
<date date-type="accepted">
<day>27</day>
<month>6</month>
<year>2016</year>
</date>
</history>
<permissions>
<copyright-statement>© Springer Science+Business Media New York 2016</copyright-statement>
</permissions>
<abstract id="Abs1">
<sec>
<title>Purpose</title>
<p>This is a comprehensive review of the literature in this field attempting to put the FMR1 gene and its evaluation into context, both in general and for the reproductive health audience.</p>
</sec>
<sec>
<title>Methods</title>
<p>Online database search of publications with systematic review of all papers relevant to ovarian reserve and assisted reproduction was done.</p>
</sec>
<sec>
<title>Results</title>
<p>Relevant papers were identified and assessed, and an attempt was made to understand, rationalize and explain the divergent views in this field of study. Seminal and original illustrations were employed.</p>
</sec>
<sec>
<title>Conclusions</title>
<p>FMR1 is a highly conserved gene whose interpretation and effect on outcomes remains controversial in the reproductive health setting. Recent re-evaluations of the commonly accepted normal range have yielded interesting tools for possibly explaining unexpected outcomes in assisted reproduction. Fragile X investigations should perhaps become more routinely assessed in the reproductive health setting, particularly following a failed treatment cycle where oocyte quality is thought to be a contributing factor, or in the presence of a surprise finding of diminished ovarian reserve in a young patient.</p>
</sec>
</abstract>
<kwd-group xml:lang="en">
<title>Keywords</title>
<kwd>Reproduction</kwd>
<kwd>Genetics</kwd>
<kwd>FMR1</kwd>
<kwd>Fragile X</kwd>
<kwd>Assisted reproductive technology</kwd>
<kwd>Testing</kwd>
</kwd-group>
<custom-meta-group>
<custom-meta>
<meta-name>issue-copyright-statement</meta-name>
<meta-value>© Springer Science+Business Media New York 2016</meta-value>
</custom-meta>
</custom-meta-group>
</article-meta>
</front>
</article>
</pmc-articleset>